Skip to content

Efficacy and Mechanism of JiangFuZhiXie Pill in Treating Incipient Ulcerative Colitis with Large Intestine Dampness-heat accompanied by Deficiency Syndrome

Efficacy and Mechanism of JiangFuZhiXie Pill in Treating Incipient Ulcerative Colitis with Large Intestine Dampness-heat accompanied by Deficiency Syndrome

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000746
Enrollment
Unknown
Registered
2026-03-27
Start date
2026-02-27
Completion date
Unknown
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative colitis

Interventions

Sponsors

Yinchuan Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Western medicine diagnosis meets the diagnostic criteria for ulcerative colitis; 2.TCM syndrome differentiation is mainly based on large intestine dampness-heat syndrome, accompanied by spleen pinching and kidney yang deficiency syndrome; 3.The age ranges from 18 to 70 years old, regardless of gender; 4.The patient gave informed consent, was willing to undergo relevant examinations, and signed the informed consent form. The informed consent process complied with the Drug Clinical Management Rules (GCP).

Exclusion criteria

Exclusion criteria: 1. Patients with severe complications, such as toxic megacolon, intestinal obstruction, stenosis, perforation and canceration; 2. Pregnant or lactating women; 3. Patients with serious diseases such as hematopoietic system, liver, kidney and endocrine system; 4. Patients with mental diseases; 5. Patients with suspected or definite history of alcohol or drug abuse; 6. Patients who are using drugs that may affect gastrointestinal function; 7. Patients with allergic history and severe food allergy to the related drugs used in this study; 8. Patients who are participating in clinical trials of other drugs.

Design outcomes

Primary

MeasureTime frame
Disease severity and patient activity (modified Mayo score);Baron endoscopic score;Gebones index;

Secondary

MeasureTime frame
Symptom and syndrome integral scale of Traditional Chinese Medicine;Blood routine examination;Stool routine examination (+ occult blood test);Liver function examination;Renal function examination;Inflammation index;

Countries

China

Contacts

Public ContactYang Yun

Yinchuan Traditional Chinese Medicine Hospital

nxycyy0605@163.com+86 189 0951 0688

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: May 1, 2026